NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

Approval will be the outcome. If you bought at the right price while maintain a medium to long term desire to hold common shares then there's not any risk.

Any small amounts of dilution will be remedied by the large increase in share price post approval. The post TLD offering was well known in SEC filings as well as PR statements made by the company.

Companies without approved drugs have been bought by Merck (Sotatercept) and Gilead (Trodelvy). So I maintain there's no risk in owning NWBO only upside for those who are patient investors.

Anyone claiming risk exists are weighing the rewards of owning this company far too low. I can't help them know what they hold.